10x Genomics (TXG) CEO gifts 4,000 shares in stock donation
Rhea-AI Filing Summary
10x Genomics, Inc. (TXG) reported that Chief Executive Officer and director Serge Saxonov made a bona fide gift of 4,000 shares of Class A Common Stock on August 20, 2026. After this gift, he directly holds 1,104,380 Class A shares and also reports indirect holdings in several family trusts for which he serves as trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,000 shares
Net Sell
4 txns
Insider
Saxonov Serge
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Class A Common Stock | 4,000 | $0.00 | $0.00 |
| holding | Class A Common Stock F1 | -- | -- | -- |
| holding | Class A Common Stock F2 | -- | -- | -- |
| holding | Class A Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 1,104,380 shares (Direct);
Class A Common Stock — 284,921 shares (Indirect, See footnote)
Footnotes (3)
- F1. The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- F2. The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- F3. The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
Key Figures
Shares gifted: 4,000 shares of Class A Common Stock
Price per share: $0.00 per share
Direct holdings after transaction: 1,104,380 shares
+2 more
5 metrics
Shares gifted
4,000 shares of Class A Common Stock
Bona fide gift reported on August 20, 2026
Price per share
$0.00 per share
Reported transaction price for the 4,000-share gift
Direct holdings after transaction
1,104,380 shares
Class A Common Stock directly owned by Serge Saxonov after the gift
Gift count
1 gift transaction
Transaction summary giftCount for this Form 4
Holding entries (indirect)
3 holding entries
Indirect ownership lines for trust-held Class A shares
Key Terms
bona fide gift, indirect ownership, trustee
3 terms
bona fide gift financial
"transaction code description is "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
indirect ownership financial
"ownership_type "indirect" with nature of ownership "See footnote""
trustee financial
"shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee"
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What insider transaction did TXG CEO Serge Saxonov report on this Form 4?
Serge Saxonov reported a bona fide gift of 4,000 shares of 10x Genomics, Inc. Class A Common Stock on August 20, 2026. The transaction is coded as a gift (code G) with a per-share transaction value of $0.00.
Was the TXG insider gift transaction made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, so the reported bona fide gift of 4,000 shares by Serge Saxonov is not identified as being made pursuant to a Rule 10b5-1 trading plan.
What is the transaction code and nature of the TXG insider transaction?
The transaction is reported with code G, described as a bona fide gift of Class A Common Stock. It reflects a disposition of 4,000 shares at a reported transaction price of $0.00 per share, consistent with a gift transfer.
Are there derivative securities involved in this TXG Form 4 filing?
No. The derivative summary section in the Form 4 is empty, and the transaction summary shows a derivativeTransactionCount of 0, indicating no derivative securities transactions were reported in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
